Khiron Life Sciences Corp. Stock News

Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) ("Khiron" or the "Company") is pleased to announce that the Company has completed the s

Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTC Pink: KHRNF) ("Khiron" or the "Company") today announced that the Company and 2518542 Alberta Ltd.

TORONTO, May 6, 2023 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company“) (TSXV: KHRN) (OTCQX: KHRNF) announced today that, further to its press release dated April 17, 2023, the O

Khiron Life Sciences Corp. (OTCQX:KHRNF) Q3 2022 Earnings Conference Call November 30, 2022 11:00 AM ET Company Participants Alvaro Torres - CEO and Co-Founder Helen Bellewood - Interim CFO Franziska

TORONTO , Nov. 18, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin Am

Khiron Life Sciences Corp. (OTCQX:KHRNF) Q2 2022 Earnings Conference Call August 29, 2022 10:00 AM ET Company Participants Paola Ricardo - Investor Relations Alvaro Torres - CEO and Co-Founder Helen B

PharmaDrug Inc said it is one step closer to streamlining its focus into a pure-play biotech company with the closing of the sale of its cannabis assets. The company said it has closed the previously

Khiron Life Sciences Corp. (TSXV: KHRN) (OTC: KHRNF) has priced and sized its overnight marketed public offering. The company intends to issue 26.70 million units at C$0.15 per unit for gross procee

PharmaDrug Inc said it has agreed to sell its German medical cannabis distributing subsidiary Pharmadrug Production GmbH to Khiron Life Sciences Corp in exchange for 5,500,000 common shares of Khiron

TORONTO , May 25, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global medical cannabis leader expanding throughout L

Khiron Life Sciences Corp. (OTCQX:KHRNF) Q4 2021 Earnings Conference Call May 2, 2022 10:00 AM ET Company Participants Alvaro Torres – Chief Executive Officer Franziska Katterbach – President-Euro

TORONTO , April 27, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout La

TORONTO , March 7, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a medical cannabis leader with core operations in Latin Ame

Medical marijuana company Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF ) (Frankfurt: A2JMZC) is opening another Zerenia location in Peru in partnership with the renowned pain clinic, CDL. Khiron In Peru Highlights This addition collectively brings the company''s total clinic count to 16 globally , which includes presence in Colombia, Peru and the United Kingdom Peru represented 5% of the total Latin America unit sales in 2021 In the second half of 2021, the company opened its first Zerenia clinic in Lima, in partnership with Clínica Montesur . Since opening the clinic, over … Full story available on Benzinga.com

Khiron has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico. The post Khiron Life Sciences Grants Options & Restricte…